Qube Research & Technologies LTD Akebia Therapeutics, Inc. Transaction History
Qube Research & Technologies LTD
- $61.9 Billion
- Q1 2024
A detailed history of Qube Research & Technologies LTD transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 2,262,676 shares of AKBA stock, worth $2.13 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,262,676
Previous 257,173
779.83%
Holding current value
$2.13 Million
Previous $318,000
1201.89%
% of portfolio
0.01%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AKBA
# of Institutions
127Shares Held
56.7MCall Options Held
937KPut Options Held
743K-
Satter Management Co., L.P.13.2MShares$12.4 Million26.98% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.23MShares$7.73 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA5.31MShares$4.99 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.65MShares$3.43 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.27MShares$3.07 Million0.0% of portfolio
About Akebia Therapeutics, Inc.
- Ticker AKBA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 183,848,992
- Market Cap $173M
- Description
- Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...